Transforming growth factors (TGFs) are a family of low molecular weight, heat and acid stable, mitogenic polypeptides that confer a malignant phenotype on untransformed cells and induce them to form progressively growing colonies in soft agar (for recent reviews, see refs. [1] [2] [3] . One group of TGFs with molecular sizes ranging from 6 to 35 kDa competes with epidermal growth factor (EGF) for receptor binding but is antigenically unrelated to this protein. These TGFs, which according to recent nomenclature are also referred to as TGFa (4) , have been detected in conditioned media of a variety of transformed cells and in extracts of transformed and embryonic tissue (reviewed in refs. 1 and 2). A low molecular size form of TGFa has recently been purified to homogeneity and chemically characterized (5).
Roberts et al. (3) have isolated an EGF-potentiated TGF, referred to as TGFB (4) , from extracts of both neoplastic and non-neoplastic tissue, which is capable of inducing large colonies of untransformed cells in the presence of low concentrations of EGF or TGFa (4) . This factor shows no competition with EGF for receptor binding. Besides these two groups, TGFs that do not compete with EGF for receptor binding and are also not potentiated by EGF have been identified in conditioned media of various transformed cells (6) (7) (8) and embryo carcinoma cells (9) and in extracts of mouse embryos (10) and fetal calf serum (11) . The exact relationship between these various TGFs is unclear, but they are all sensitive to proteolytic enzymes and require intact disulfide bridges for activity (1) (2) (3) .
Neuroblastoma, a common neoplasm of childhood, is one of the few solid tumors that may occasionally regress spontaneously, probably because cells undergo differentiation by which they lose their oncogenic properties (12) (13) (14) . Cell lines derived from such tumors have therefore gained widespread attention as model systems f6r studying neuronal differentiation (14, 15) . A cell line that has been investigated particularly with respect to its cell growth characteristics is mouse neuroblastoma Neuro-2A (16, 17) . When cultured in the presence of serum, this cell line proliferates very rapidly with a doubling time of <8 hr and shows a remarkably high G1-to S-phase transition probability, demonstrating an efficient cell cycle triggering by growth-stimulating hormones (18) . In this paper we show that this cell line can grow almost as rapidly in a chemically defined serum-free medium in the absence of any externally added polypeptide growth factor. Analysis of conditioned serum-free medium of exponentially growing cells shows that Neuro-2A produces an acid-stable 15-to 20-kDa TGF with strong mitogenic activity, which does not compete with EGF for receptor binding. These results suggest that this neuroblastoma line can grow autonomously as a result of autocrine production of polypeptide growth factors.
MATERIALS AND METHODS
Cell Culture. C1300 mouse neuroblastoma cells, clone Neuro-2A, were grown in a 1:1 mixture of Dulbecco's modified Eagle's medium (DME medium)/Ham's F-12 medium containing 15 mM Hepes and 17.6 mM NaHCO3 (pH 7.6) (referred to as DFBH medium) at 37°C. For routine growth and subculturing this medium was supplemented with 7.5% fetal calf serum (FCS; Flow Laboratories). For serum-free growth the DFBH medium was supplemented with 30 nM Na2SeO3 and 10 ,ug of human transferrin (Sigma) per ml. For collecting Neuro-2A conditioned medium, 107 Neuro-2A cells were plated in a 850-cm2 plastic roller bottle (Falcon). After 24 hr, the medium was exchanged for 30 ml of serumfree medium, which was discarded 8 hr later. The cells were then grown for 24 hr in 75 ml and subsequently for 16 hr in 100 ml of serum-free medium. The 175 ml of conditioned medium collected was passed through an AP-15 prefilter (Millipore) and lyophilized in the presence of 1 ,ug of phenylmethylsulfonyl fluoride (Sigma) per ml.
TGF Isolation. Lyophilized Neuro-2A conditioned serumfree medium was extracted with 1 M HOAc as described (6) and run on a 2.5 x 100 cm Bio-Gel P-100 column (100-200
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RESULTS
Serum-Free Growth of Neuro-2A Cells. Fig. 1 shows that Neuro-2A cells grow very rapidly in DFBH medium/10% FCS, with a doubling time of 8 hr over a wide density range. In serum-free medium cells grow with a doubling time of =10 hr, also at low transferrin concentration (10 ,g/ml) and in the absence of insulin. Transferrin is essential only during subculturing of the cells in serum-free medium (19) and should be considered as a survival factor more than as a mitogen. The observation that Neuro-2A cells are able to proliferate rapidly in serum-free medium without externally added growth factors contrasts with the behavior of most other cell types, including transformed lines (20) , and also with that of rat B104 neuroblastoma cells (21 approach differs essentially from that of most other studies, in which conditioned media of near-confluent cultures are collected.
Bio-Gel P-100 Chromatography. Fig. 2 shows various characteristics of Neuro-2A conditioned serum-free medium, after gel chromatography on a Bio-Gel P-100 column in 1 M HOAc. As judged from the absorbance at 280 nm ( Fig. 2A) 0.8 ml tested; n = 2) and induction of NRK soft agar growth (0; 0.5 ml tested; n = 2). n denotes number of independent experiments. The column was calibrated with the marker enzymes carbonic anhydrase (29 kDa), RNase (13.7 kDa), and insulin (6 kDa).
compete with EGF for receptor binding. The 15-to 20-kDa mitogenic activity derived from Neuro-2A conditioned medium, which coincides with a principal soft agar growth-inducing activity, has been analyzed in more detail. This activity will be referred to as neuroblastoma-derived TGF (ND-TGF). Pooling of fractions 45-70 resulted in -1.5 mg of protein per liter of conditioned medium.
Mitogenic Activity of ND-TGF. Fig. 3 shows dose-response curves for the mitogenic stimulation of quiescent 3T3 retarded during elution on Bio-Gel columns, resulting in a broad, asymmetric elution profile with aberrant molecular sizes. On the other hand, there is soft agar growth-inducing activity in the absence of EGF, especially in that region of the column containing the mitogenic ND-TGF. Table 2 shows that this latter region can also induce low levels of soft agar growth in NR6-6 cells. No additional stimulation by EGF is seen in this case, demonstrating that potentiation of TGF/3 does not occur under these conditions. These data show that Neuro-2A conditioned medium contains soft agar growth-inducing activity distinct from that mediated by the EGF-potentiated TGF,8.
To investigate the extent to which the mitogenic activity of ND-TGF parallels its soft agar growth-inducing activity, ND-TGF obtained by Bio-Gel P-100 chromatography was rechromatographed on a Bio-Gel P-30 column in 1 M HOAc. Fig. 4A shows a virtually symmetric elution profile of mitogenic activity, following the protein profile. In the presence of 2 ng of EGF per ml, the mitogenic activity of each fraction is increased approximately by a constant factor, demonstrating the additional mitogenic activities of EGF and ND-TGF. Fig. 4B shows that the soft agar growth-inducing activity of 1.0 1.6 Bio-Gel P-100 column fractions of Neuro-2A conditioned medium were pooled. In each assay, material obtained from 0.1 liter of conditioned medium was tested (which differs from the amounts used in Fig. 2) . EGF was added to 2 ng/ml. *Equals ND-TGF.
the various P-30 column fractions in the absence of EGF follows a similar symmetrical elution profile, reaching a maximum of 15% colony formation of NRK cells. However, in the presence of 2 ng of EGF per ml, a strong increase in the number of colonies is observed due to potentation of TGFB. In this case, the soft agar growth activity does not follow the above symmetrical profile but is present in all fractions tested. This is because TGF3 elutes again as a broad band from the P-30 column. Since TGFB lacks mitogenic activity both in the absence and presence of EGF (23), this demonstrates that ND-TGF and TGFB are unrelated factors, which behave differently upon rechromatography on a Bio-Gel column.
DISCUSSION
Neuro-2A cells cultured in serum-free medium produce a strongly mitogenic TGF (ND-TGF) that differs from other TGFs described to date. ND-TGF does not compete with EGF for receptor binding as does TGFa, and, unlike TGFp, it has strong mitogenic activity. Although Neuro-2A cells can grow in the absence of insulin, ND-TGF seems to be unrelated to any insulin-like growth factor, in view of its high molecular size and soft agar growth-inducing activity. Furthermore, control experiments show that ND-TGF is present in neither unconditioned, transferrin-containing, serum-free The experiments on the effects of EGF and ND-TGF on the induction of soft agar growth of NRK cells (shown in Table 2 and Fig. 4) indicate that, besides the mitogenic factor ND-TGF, Neuro-2A cells also produce a factor similar to TGF/3. On the other hand, the observation that in the absence of EGF the soft agar growth-inducing activity of ND-TGF coincides with its mitogenic activity strongly suggests that ND-TGF itself is involved in the process of phenotypic transformation. Since our ND-TGF preparations contain no EGF or TGFa, this demonstrates that ND-TGF can induce phenotypic transformation irrespective of the presence of a growth factor binding to the EGF receptor. This is also illustrated by the fact that ND-TGF can induce soft agar growth of NR6-6 cells. However, interpretation of data on the induction of soft agar growth by polypeptide growth factors is always hampered by the fact that these experiments are carried out in the presence of 10% serum, which by itself contains various growth factors. We have recently developed a growth factor defined culture medium for NRK cells, consisting of a basal medium with insulin and EGF and supplemented with bovine serum in which all growth factor activities have been inactivated by treatment with dithiothreitol. Using this medium in the soft agar growth assay, it has been shown that EGF by itself cannot induce colonies, whereas ND-TGF, both in the presence and absence of EGF, can induce up to 10% colony formation of NRK cells (unpublished data). Since TGFf is still present in our preparations, two possibilities should be considered. Either ND-TGF can induce soft agar growth by itself or it can only express this activity in the additional presence of TGFP, as EGF and TGFa. It will require further purification of ND-TGF to discriminate between these two possibilities.
The observation that Neuro-2A cells can proliferate in the absence of externally added growth factors suggests, but does not prove, that these cells benefit from the autocrine production of growth factors. Direct evidence for the involvement of ND-TGF in the proliferation of Neuro-2A cells should come from experiments with antibodies raised against this growth factor. Since neuroblastoma cells both in vivo and in vitro have retained the ability to differentiate into mature nerve cells and thereby lose their oncogenic properties, it is an appealing idea that blockage of ND-TGF production or inhibition of its action, for example by means of a specific antibody, might result in an irreversible elimination of neuroblastoma cell proliferation.
